COVID-19 vaccination is associated with reduced risk of new-onset atrial fibrillation following COVID-19 infection

1. COVID-19 vaccination was associated with a reduced 24-month risk of new-onset atrial fibrillation/flutter after COVID-19 infection. Evidence Rating Level: 2 (Good) COVID-19 infection has been linked with cardiovascular complications such as new-onset atrial fibrillation/flutter (NOAF). While there is evidence of the COVID-19 vaccine being protective against the development of long COVID, its…